This edition of the Market Review features Mr. Mathew Obi Azoji, the Managing Director/Chief Executive Officer of Neimeth Pharmaceuticals Plc, who spoke on “Repositioning the Nigerian Pharmaceutical Industry for Global Competitiveness” with Ottoabasi Abasiekong on Tuesday, August 16th, 2022.
The conversation covered the following issues:
- Impact of the CBN N100bn Pharmaceutical Industry Intervention
- Why Neimeth Is Raising N3.67bn Through the Capital Market
- What Investors Should Expect in terms of ROI
- How the Pharmaceutical Manufacturing Industry is Navigating FX and Logistics Challenges.
- Outlook for the Nigerian Pharmaceutical Industry